Pluripotent stem cells in disease modelling and drug discovery

Y Avior, I Sagi, N Benvenisty - Nature reviews Molecular cell biology, 2016 - nature.com
Experimental modelling of human disorders enables the definition of the cellular and
molecular mechanisms underlying diseases and the development of therapies for treating …

Epigenetic aberrations in human pluripotent stem cells

S Bar, N Benvenisty - The EMBO journal, 2019 - embopress.org
Human pluripotent stem cells (hPSCs) are being increasingly utilized worldwide in
investigating human development, and modeling and discovering therapies for a wide range …

The noncoding RNA IPW regulates the imprinted DLK1-DIO3 locus in an induced pluripotent stem cell model of Prader-Willi syndrome

Y Stelzer, I Sagi, O Yanuka, R Eiges, N Benvenisty - Nature genetics, 2014 - nature.com
Parental imprinting is a form of epigenetic regulation that results in parent-of-origin
differential gene expression. To study Prader-Willi syndrome (PWS), a developmental …

Comparable frequencies of coding mutations and loss of imprinting in human pluripotent cells derived by nuclear transfer and defined factors

B Johannesson, I Sagi, A Gore, D Paull, M Yamada… - Cell stem cell, 2014 - cell.com
The recent finding that reprogrammed human pluripotent stem cells can be derived by
nuclear transfer into human oocytes as well as by induced expression of defined factors has …

Creating patient-specific neural cells for the in vitro study of brain disorders

KJ Brennand, MC Marchetto, N Benvenisty, O Brüstle… - Stem cell reports, 2015 - cell.com
As a group, we met to discuss the current challenges for creating meaningful patient-specific
in vitro models to study brain disorders. Although the convergence of findings between …

How does reprogramming to pluripotency affect genomic imprinting?

V Perrera, G Martello - Frontiers in Cell and Developmental Biology, 2019 - frontiersin.org
Human induced Pluripotent Stem Cells (hiPSCs) have the capacity to generate a wide range
of somatic cells, thus representing an ideal tool for regenerative medicine. Patient-derived …

High levels of unfolded protein response component CHAC1 associates with cancer progression signatures in malignant breast cancer tissues

V Mehta, P Suman, H Chander - Clinical and Translational Oncology, 2022 - Springer
Purpose The aberrant mRNA expression of a UPR component Cation transport regulator
homolog 1 (CHAC1) has been reported to be associated with poor survival in breast and …

Elevated mRNA expression of CHAC1 splicing variants is associated with poor outcome for breast and ovarian cancer patients

G Goebel, R Berger, AM Strasak, D Egle… - British journal of …, 2012 - nature.com
Background: The role of CHAC1 (cation transport regulator-like protein 1), a recently
identified component of the unfolded protein response (UPR) pathway, in gynaecological …

Systematic review of induced pluripotent stem cell technology as a potential clinical therapy for spinal cord injury

AS Kramer, AR Harvey, GW Plant… - Cell …, 2013 - journals.sagepub.com
Transplantation therapies aimed at repairing neurodegenerative and neuropathological
conditions of the central nervous system (CNS) have utilized and tested a variety of cell …

Expanding the boundaries of embryonic stem cells

U Ben-David, O Kopper, N Benvenisty - Cell Stem Cell, 2012 - cell.com
The boundaries of embryonic stem cell (ESC) research have extended considerably in
recent years in several important ways. Alongside a deeper understanding of the pluripotent …